title: Global mapping of H3K4me3 and H3K27me3 reveals chromatin state-based regulation of human monocyte-derived dendritic cells in different environments.
abstract: Depending on the environment, dendritic cells (DCs) may become active or tolerogenic, but little is known about whether heritable epigenetic modifications are involved in these processes. Here, we have found that epigenetic histone modifications can regulate the differentiation of human monocyte-derived DCs (moDCs) into either activated or tolerized DCs. The inhibition or silencing of methyltransferases or methylation-associated factors affects the expression of multiple genes. Genome mapping of transforming growth factor (TGF-β)- or lipopolysaccharide (LPS)-associated H3K4 trimethylation (H3K4me3) and H3K27 trimethylation (H3K27me3) demonstrated the presence of histone modification of gene expression in human TGF-β- or LPS-conditioned moDCs. Although the upregulated or downregulated genes were not always associated with H3K4me3 and/or H3K27me3 modifications in TGF-β-conditioned (tolerized) or LPS-conditioned (activated) moDCs, some of these genes may be regulated by the increased and/or decreased H3K4me3 or H3K27me3 levels or by the alteration of these epigenetic marks, especially in TGF-β-conditioned moDCs. Thus, our results suggested that the differentiation and function of moDCs in tumor and inflammation environments are associated with the modification of the H3K4me3 and K3K27me3 epigenetic marks.
authors.affiliation: Department of Immunology, Nankai University School of Medicine, Nankai University, Tianjin, China.
authors.forename: Y
authors.initials: Y
authors.lastname: Huang
authors.forename: S
authors.initials: S
authors.lastname: Min
authors.forename: Y
authors.initials: Y
authors.lastname: Lui
authors.forename: J
authors.initials: J
authors.lastname: Sun
authors.forename: X
authors.initials: X
authors.lastname: Su
authors.forename: Y
authors.initials: Y
authors.lastname: Liu
authors.forename: Y
authors.initials: Y
authors.lastname: Zhang
authors.forename: D
authors.initials: D
authors.lastname: Han
authors.forename: Y
authors.initials: Y
authors.lastname: Che
authors.forename: C
authors.initials: C
authors.lastname: Zhao
authors.forename: B
authors.initials: B
authors.lastname: Ma
authors.forename: R
authors.initials: R
authors.lastname: Yang
mesh_terms: D002454:Cell Differentiation; D060833:Cellular Microenvironment; D002843:Chromatin / Q000235:genetics / Q000378:metabolism*; D002874:Chromosome Mapping / Q000379:methods*; D019295:Computational Biology; D003713:Dendritic Cells / Q000166:cytology / Q000187:drug effects / Q000276:immunology*; D044127:Epigenesis, Genetic; D020868:Gene Silencing; D006649:Histocompatibility Antigens / Q000235:genetics / Q000276:immunology / Q000378:metabolism; D011495:Histone-Lysine N-Methyltransferase / Q000235:genetics / Q000276:immunology / Q000378:metabolism; D006657:Histones / Q000235:genetics / Q000276:immunology / Q000378:metabolism*; D006801:Humans; D008070:Lipopolysaccharides / Q000276:immunology / Q000494:pharmacology; D008745:Methylation; D009000:Monocytes / Q000166:cytology; D034741:RNA, Small Interfering / Q000235:genetics / Q000378:metabolism; D014162:Transfection; D016212:Transforming Growth Factor beta
chemical_list: D002843:Chromatin; D006649:Histocompatibility Antigens; D006657:Histones; D008070:Lipopolysaccharides; D034741:RNA, Small Interfering; D016212:Transforming Growth Factor beta; C445405:EHMT2 protein, human; D011495:Histone-Lysine N-Methyltransferase